Search

Alerten

Alerten

ubidecarenone

Manufacturer:

Mega Lifesciences

Distributor:

Maxxcare
Concise Prescribing Info
Contents
Coenzyme Q10
Indications/Uses
25 mg: Supportive treatment for patients w/ CHF. 50 mg: Periodontal disease. Prevention of coenzyme Q10 depletion in concomitant use w/ HMG-CoA reductase inhibitor. Adjunctive therapy for CHF.
Click to view Alerten detailed prescribing information
Dosage/Direction for Use
25 mg 1 cap daily. 50 mg 1-2 cap bd-tds.
Click to view Alerten detailed prescribing information
Administration
Should be taken with food.
Contraindications
Severe liver or kidney disease. Pregnancy & lactation. Childn.
Click to view Alerten detailed prescribing information
Special Precautions
May decrease warfarin effectiveness.
Click to view Alerten detailed prescribing information
Adverse Reactions
Nausea, diarrhea & epigastric distress particularly w/ higher doses (≥200 mg daily).
Caution For Usage
For caution against possible variation of physical aspect of medicine... Click to view Alerten detailed prescribing information
Storage
View Alerten storage conditions for details to ensure optimal shelf-life.
Description
View Alerten description for details of the chemical structure and excipients (inactive components).
Action
View Alerten mechanism of action for pharmacodynamics and pharmacokinetics details.
MIMS Class
Other Cardiovascular Drugs
ATC Classification
C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.
Presentation/Packing
Form
Alerten softgel cap 25 mg
Packing/Price
3 × 10's
Form
Alerten softgel cap 50 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in